Knoll Capital Management as of June 30, 2023
Portfolio Holdings for Knoll Capital Management
Knoll Capital Management holds 26 positions in its portfolio as reported in the June 2023 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Aldeyra Therapeutics (ALDX) | 30.8 | $25M | 3.0M | 8.39 | |
| Biohaven Pharmaceutical Holding | 13.1 | $11M | 450k | 23.92 | |
| Avadel Pharmaceuticals Sponsored Adr | 10.0 | $8.2M | 500k | 16.48 | |
| Hookipa Pharma Inc equity | 5.9 | $4.9M | 5.5M | 0.88 | |
| Applied Therapeutics (APLT) | 5.4 | $4.4M | 3.5M | 1.28 | |
| Verona Pharma Sponsored Ads (VRNA) | 5.1 | $4.2M | 200k | 21.14 | |
| Vaneck Gold Miners ETF Gold Miners ETF (GDX) | 3.4 | $2.8M | 92k | 30.11 | |
| Global X Silver Miners ETF 37954Y848 Global X Silver (SIL) | 2.8 | $2.3M | 90k | 25.99 | |
| Entera Bio SHS (ENTX) | 2.5 | $2.1M | 2.5M | 0.84 | |
| Vaneck Junior Gold Miners ETF Junior Hold Mine (GDXJ) | 2.3 | $1.9M | 53k | 35.66 | |
| Ocular Therapeutix (OCUL) | 1.9 | $1.5M | 296k | 5.16 | |
| Booz Allen Hamilton HLDG COR Cl A (BAH) | 1.8 | $1.5M | 13k | 111.60 | |
| Visa Com Cl A (V) | 1.4 | $1.2M | 4.9k | 237.48 | |
| Thermo Fisher Scientific (TMO) | 1.3 | $1.1M | 2.1k | 521.75 | |
| Altria (MO) | 1.3 | $1.0M | 23k | 45.30 | |
| CVS Caremark Corporation (CVS) | 1.2 | $1.0M | 15k | 69.13 | |
| Franco-Nevada Corporation (FNV) | 1.2 | $998k | 7.0k | 142.60 | |
| Silvercrest Metals (SILV) | 1.2 | $996k | 170k | 5.86 | |
| Northrop Grumman Corporation (NOC) | 1.2 | $987k | 2.2k | 455.80 | |
| Osisko Gold Royalties (OR) | 1.2 | $969k | 400k | 2.42 | |
| Omega Therapeutics (OMGA) | 1.2 | $969k | 173k | 5.60 | |
| Seabridge Gold (SA) | 1.2 | $964k | 80k | 12.05 | |
| Orgenesis | 1.1 | $882k | 635k | 1.39 | |
| Altimmune Com New (ALT) | 0.7 | $614k | 174k | 3.53 | |
| Ocuphire Pharma (IRD) | 0.5 | $434k | 100k | 4.34 | |
| Bioxcel Therapeutics (BTAI) | 0.2 | $200k | 30k | 6.66 |
